Ascopiave SpA
MIL:ASC
Ascopiave SpA
MIL:ASC
Price:
3.03
EUR
2.02%
Market Cap:
655.8m
EUR
Balance Sheet
Balance Sheet Decomposition
Ascopiave SpA
Ascopiave SpA
| Current Assets | 154m |
| Cash & Short-Term Investments | 17.7m |
| Receivables | 120.8m |
| Other Current Assets | 15.5m |
| Non-Current Assets | 1.3B |
| Long-Term Investments | 310.7m |
| PP&E | 158.5m |
| Intangibles | 776.9m |
| Other Non-Current Assets | 41.8m |
Balance Sheet
Ascopiave SpA
Ascopiave SpA
Currency: EUR
Millions
Annual
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
101
|
28
|
9
|
16
|
67
|
67
|
44
|
85
|
154
|
52
|
|
| Cash |
101
|
28
|
9
|
16
|
67
|
67
|
22
|
43
|
77
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
22
|
43
|
77
|
52
|
|
| Short-Term Investments |
17
|
3
|
0
|
0
|
1
|
7
|
1
|
1
|
1
|
2
|
|
| Total Receivables |
226
|
219
|
196
|
217
|
213
|
91
|
113
|
53
|
158
|
118
|
|
| Accounts Receivables |
148
|
172
|
148
|
157
|
167
|
43
|
34
|
27
|
20
|
33
|
|
| Other Receivables |
78
|
47
|
48
|
60
|
46
|
47
|
79
|
26
|
138
|
84
|
|
| Inventory |
2
|
4
|
4
|
4
|
6
|
8
|
15
|
8
|
7
|
8
|
|
| Other Current Assets |
1
|
1
|
2
|
2
|
1
|
1
|
0
|
1
|
7
|
5
|
|
| Total Current Assets |
338
|
255
|
211
|
239
|
287
|
173
|
151
|
106
|
250
|
185
|
|
| PP&E Net |
37
|
35
|
32
|
32
|
33
|
35
|
33
|
58
|
138
|
156
|
|
| PP&E Gross |
37
|
35
|
32
|
32
|
33
|
35
|
33
|
58
|
138
|
156
|
|
| Accumulated Depreciation |
23
|
25
|
27
|
32
|
34
|
39
|
42
|
47
|
143
|
152
|
|
| Intangible Assets |
314
|
317
|
317
|
347
|
352
|
567
|
577
|
598
|
698
|
705
|
|
| Goodwill |
81
|
81
|
81
|
81
|
81
|
48
|
49
|
49
|
61
|
62
|
|
| Long-Term Investments |
69
|
68
|
69
|
69
|
69
|
452
|
518
|
524
|
439
|
311
|
|
| Other Long-Term Assets |
30
|
27
|
24
|
24
|
23
|
23
|
34
|
35
|
60
|
43
|
|
| Other Assets |
81
|
81
|
81
|
81
|
81
|
48
|
49
|
49
|
61
|
62
|
|
| Total Assets |
867
N/A
|
782
-10%
|
733
-6%
|
792
+8%
|
846
+7%
|
1 298
+54%
|
1 363
+5%
|
1 371
+1%
|
1 648
+20%
|
1 462
-11%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
136
|
123
|
103
|
118
|
131
|
52
|
67
|
34
|
180
|
73
|
|
| Accrued Liabilities |
6
|
7
|
6
|
7
|
7
|
8
|
6
|
6
|
8
|
12
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
185
|
98
|
64
|
80
|
131
|
137
|
166
|
201
|
184
|
150
|
|
| Other Current Liabilities |
21
|
41
|
32
|
32
|
22
|
39
|
27
|
20
|
45
|
11
|
|
| Total Current Liabilities |
348
|
268
|
206
|
237
|
291
|
236
|
266
|
261
|
417
|
246
|
|
| Long-Term Debt |
54
|
44
|
35
|
55
|
55
|
135
|
196
|
186
|
280
|
298
|
|
| Deferred Income Tax |
24
|
20
|
17
|
16
|
15
|
22
|
13
|
13
|
20
|
18
|
|
| Minority Interest |
4
|
5
|
6
|
5
|
4
|
0
|
0
|
0
|
20
|
10
|
|
| Other Liabilities |
33
|
30
|
31
|
34
|
37
|
31
|
35
|
42
|
44
|
46
|
|
| Total Liabilities |
462
N/A
|
367
-21%
|
295
-20%
|
346
+17%
|
402
+16%
|
425
+6%
|
509
+20%
|
502
-1%
|
781
+56%
|
617
-21%
|
|
| Equity | |||||||||||
| Common Stock |
234
|
234
|
234
|
234
|
234
|
234
|
234
|
234
|
234
|
234
|
|
| Retained Earnings |
189
|
198
|
221
|
229
|
226
|
666
|
675
|
690
|
687
|
666
|
|
| Treasury Stock |
18
|
18
|
18
|
18
|
17
|
27
|
56
|
55
|
55
|
55
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
405
N/A
|
415
+2%
|
438
+5%
|
446
+2%
|
444
0%
|
873
+97%
|
854
-2%
|
869
+2%
|
866
0%
|
845
-2%
|
|
| Total Liabilities & Equity |
867
N/A
|
782
-10%
|
733
-6%
|
792
+8%
|
846
+7%
|
1 298
+54%
|
1 363
+5%
|
1 371
+1%
|
1 648
+20%
|
1 462
-11%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
222
|
222
|
222
|
222
|
223
|
224
|
217
|
217
|
217
|
217
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
